newsfilter
← Latest News
GlobeNewswire·

Cellectis to Report Third Quarter Financial Results on November 12, 2026

NEW YORK, Nov. 09, 2026 (GLOBE NEWSWIRE) -- Cellectis (the "Company") (NASDAQ:CLLS), a genome engineering company developing genetic medicines for diseases that today demand a lifetime of treatment, will